Möchten Sie immer auf dem neuesten Stand bleiben?

MINNEAPOLIS, MINNESOTA--(Marketwired - Sept. 2, 2015) - DiaMedica Inc. (TSX VENTURE:DMA)(OTCQB:DMCAF), today announced that the Company will be presenting at the Rodman & Renshaw 17th...

MINNEAPOLIS, MINNESOTA--(Marketwired - July 16, 2015) - DiaMedica Inc. (TSX VENTURE:DMA)(OTCQB:DMCAF) (the "Company"), announces that it has been listed for trading on the OTCQB®...

MINNEAPOLIS, MINNESOTA--(Marketwired - June 19, 2015) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA), announced today the closing of its previously announced non-brokered private...

MINNEAPOLIS, MINNESOTA--(Marketwired - June 11, 2015) - NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES DiaMedica Inc....

MINNEAPOLIS, MINNESOTA--(Marketwired - June 5, 2015) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA), announces that, subject to TSX Venture Exchange approval, it is undertaking a...

MINNEAPOLIS, MINNESOTA--(Marketwired - May 27, 2015) - DiaMedica Inc. (TSX VENTURE:DMA), announced that Mr. Rick Pauls, President and Chief Executive Officer, will make an overview...

MINNEAPOLIS, MINNESOTA--(Marketwired - March 19, 2015) - DiaMedica Inc. (TSX VENTURE:DMA) today, announced that the Company has been selected to present at the 12th Annual BIO Asia...

MINNEAPOLIS, MINNESOTA--(Marketwired - March 16, 2015) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA), announced today, further to its news release of February 27, 2015, the closing...

MINNEAPOLIS, MINNESOTA--(Marketwired - Feb. 27, 2015) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA), announces that, subject to TSX Venture Exchange approval, it is undertaking a...

MINNEAPOLIS, MINNESOTA--(Marketwired - Feb. 2, 2015) - DiaMedica Inc. (TSX VENTURE:DMA) today, announced that the company will pursue the development of DM199, its recombinant form of the...